Download PDF
Semin Thromb Hemost 2013; 39(04): 329-337
DOI: 10.1055/s-0033-1334483
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Plasminogen Receptors: The First Quarter Century

Lindsey A. Miles
1   Department of Cell and Molecular Biology, The Scripps Research Institute, La Jolla, California
,
Robert J. Parmer
2   Department of Medicine, University of California San Diego, Veterans Administration San Diego Healthcare System, San Diego, California
› Author Affiliations
Further Information

Publication History

Publication Date:
26 March 2013 (online)

    Permissions and Reprints

Abstract

The interaction of plasminogen with cell surfaces results in promotion of plasmin formation and retention on the cell surface. This results in arming cell surfaces with the broad-spectrum proteolytic activity of plasmin. Over the past quarter century, key functional consequences of the association of plasmin with the cell surface have been elucidated. Physiologic and pathophysiologic processes with plasmin-dependent cell migration as a central feature include inflammation, wound healing, oncogenesis, metastasis, myogenesis, and muscle regeneration. Cell surface plasmin also participates in neurite outgrowth and prohormone processing. Furthermore, plasmin-induced cell signaling also affects the functions of inflammatory cells, via production of cytokines, reactive oxygen species, and other mediators. Finally, plasminogen receptors regulate fibrinolysis. In this review, we highlight emerging data that shed light on longstanding controversies and raise new issues in the field. We focus on (1) the impact of the recent X-ray crystal structures of plasminogen and the development of antibodies that recognize cell-induced conformational changes in plasminogen on our understanding of the interaction of plasminogen with cells; (2) the relationship between apoptosis and plasminogen binding to cells; (3) the current status of our understanding of the molecular identity of plasminogen receptors and the discovery of a structurally unique novel plasminogen receptor, Plg-RKT; (4) the determinants of the interplay between distinct plasminogen receptors and cellular functions; and (5) new insights into the role of colocalization of plasminogen and plasminogen activator receptors on the cell surface.

Keywords

α-enolase - actin - annexin A2 - plasminogen receptors - Plg-RKT - S100A10
 

  • References

  • 1 Miles LA, Plow EF. Binding and activation of plasminogen on the platelet surface. J Biol Chem 1985; 260 (7) 4303-4311
    PubMedSearch in Google Scholar
  • 2 Stricker RB, Wong D, Shiu DT, Reyes PT, Shuman MA. Activation of plasminogen by tissue plasminogen activator on normal and thrombasthenic platelets: effects on surface proteins and platelet aggregation. Blood 1986; 68 (1) 275-280
    CrossrefPubMedSearch in Google Scholar
  • 3 Hajjar KA, Harpel PC, Jaffe EA, Nachman RL. Binding of plasminogen to cultured human endothelial cells. J Biol Chem 1986; 261 (25) 11656-11662
    PubMedSearch in Google Scholar
  • 4 Loscalzo J, Vaughan DE. Tissue plasminogen activator promotes platelet disaggregation in plasma. J Clin Invest 1987; 79 (6) 1749-1755
    CrossrefPubMedSearch in Google Scholar
  • 5 Ellis V, Behrendt N, Danø K. Plasminogen activation by receptor-bound urokinase. A kinetic study with both cell-associated and isolated receptor. J Biol Chem 1991; 266 (19) 12752-12758
    PubMedSearch in Google Scholar
  • 6 Gonias SL, Braud LL, Geary WA, VandenBerg SR. Plasminogen binding to rat hepatocytes in primary culture and to thin slices of rat liver. Blood 1989; 74 (2) 729-736
    PubMedSearch in Google Scholar
  • 7 Duval-Jobe C, Parmely MJ. Regulation of plasminogen activation by human U937 promonocytic cells. J Biol Chem 1994; 269 (33) 21353-21357
    PubMedSearch in Google Scholar
  • 8 Félez J, Miles LA, Fábregas P, Jardí M, Plow EF, Lijnen RH. Characterization of cellular binding sites and interactive regions within reactants required for enhancement of plasminogen activation by tPA on the surface of leukocytic cells. Thromb Haemost 1996; 76 (4) 577-584
    PubMedSearch in Google Scholar
  • 9 Longstaff C, Merton RE, Fabregas P, Felez J. Characterization of cell-associated plasminogen activation catalyzed by urokinase-type plasminogen activator, but independent of urokinase receptor (uPAR, CD87). Blood 1999; 93 (11) 3839-3846
    PubMedSearch in Google Scholar
  • 10 Sinniger V, Merton RE, Fabregas P, Felez J, Longstaff C. Regulation of tissue plasminogen activator activity by cells. Domains responsible for binding and mechanism of stimulation. J Biol Chem 1999; 274 (18) 12414-12422
    CrossrefPubMedSearch in Google Scholar
  • 11 Plow EF, Freaney DE, Plescia J, Miles LA. The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type. J Cell Biol 1986; 103 (6 Pt 1) 2411-2420
    CrossrefPubMedSearch in Google Scholar
  • 12 Hall SW, Humphries JE, Gonias SL. Inhibition of cell surface receptor-bound plasmin by alpha 2-antiplasmin and alpha 2-macroglobulin. J Biol Chem 1991; 266 (19) 12329-12336
    PubMedSearch in Google Scholar
  • 13 Miles LA, Plow EF. Receptor mediated binding of the fibrinolytic components, plasminogen and urokinase, to peripheral blood cells. Thromb Haemost 1987; 58 (3) 936-942
    PubMedSearch in Google Scholar
  • 14 Silverstein RL, Friedlander Jr RJ, Nicholas RL, Nachman RL. Binding of Lys-plasminogen to monocytes/macrophages. J Clin Invest 1988; 82 (6) 1948-1955
    CrossrefPubMedSearch in Google Scholar
  • 15 Miles LA, Levin EG, Plescia J, Collen D, Plow EF. Plasminogen receptors, urokinase receptors, and their modulation on human endothelial cells. Blood 1988; 72 (2) 628-635
    PubMedSearch in Google Scholar
  • 16 Gonzalez-Gronow M, Gawdi G, Pizzo SV. Characterization of the plasminogen receptors of normal and rheumatoid arthritis human synovial fibroblasts. J Biol Chem 1994; 269 (6) 4360-4366
    PubMedSearch in Google Scholar
  • 17 Parmer RJ, Mahata M, Gong Y , et al. Processing of chromogranin A by plasmin provides a novel mechanism for regulating catecholamine secretion. J Clin Invest 2000; 106 (7) 907-915
    CrossrefPubMedSearch in Google Scholar
  • 18 Jiang Q, Yasothornsrikul S, Taupenot L, Miles LA, Parmer RJ. The local chromaffin cell plasminogen/plasmin system and the regulation of catecholamine secretion. Ann N Y Acad Sci 2002; 971: 445-449
    CrossrefPubMedSearch in Google Scholar
  • 19 Durliat M, Komano O, Correc P , et al. Plasminogen receptors on rat colon carcinoma cells. Br J Cancer 1992; 66 (1) 51-56
    CrossrefPubMedSearch in Google Scholar
  • 20 Hembrough TA, Vasudevan J, Allietta MM, Glass II WF, Gonias SL. A cytokeratin 8-like protein with plasminogen-binding activity is present on the external surfaces of hepatocytes, HepG2 cells and breast carcinoma cell lines. J Cell Sci 1995; 108 (Pt 3) 1071-1082
    PubMedSearch in Google Scholar
  • 21 Lacroix R, Sabatier F, Mialhe A , et al. Activation of plasminogen into plasmin at the surface of endothelial microparticles: a mechanism that modulates angiogenic properties of endothelial progenitor cells in vitro. Blood 2007; 110 (7) 2432-2439
    CrossrefPubMedSearch in Google Scholar
  • 22 Lacroix R, Plawinski L, Robert S , et al. Leukocyte- and endothelial-derived microparticles: a circulating source for fibrinolysis. Haematologica 2012; 97 (12) 1864-1872
    CrossrefPubMedSearch in Google Scholar
  • 23 Bhattacharya S, Ploplis VA, Castellino FJ. Bacterial plasminogen receptors utilize host plasminogen system for effective invasion and dissemination. J Biomed Biotechnol 2012; 2012: 482096
    PubMedSearch in Google Scholar
  • 24 Sanderson-Smith ML, De Oliveira DM, Ranson M, McArthur JD. Bacterial plasminogen receptors: mediators of a multifaceted relationship. J Biomed Biotechnol 2012; 2012: 272148
    PubMedSearch in Google Scholar
  • 25 Ploplis VA, French EL, Carmeliet P, Collen D, Plow EF. Plasminogen deficiency differentially affects recruitment of inflammatory cell populations in mice. Blood 1998; 91 (6) 2005-2009
    CrossrefPubMedSearch in Google Scholar
  • 26 Plow EF, Ploplis VA, Busuttil S, Carmeliet P, Collen D. A role of plasminogen in atherosclerosis and restenosis models in mice. Thromb Haemost 1999; 82 (Suppl. 01) 4-7
    PubMedSearch in Google Scholar
  • 27 Busuttil SJ, Ploplis VA, Castellino FJ, Tang L, Eaton JW, Plow EF. A central role for plasminogen in the inflammatory response to biomaterials. J Thromb Haemost 2004; 2 (10) 1798-1805
    CrossrefPubMedSearch in Google Scholar
  • 28 Romer J, Bugge TH, Pyke C , et al. Impaired wound healing in mice with a disrupted plasminogen gene. Nat Med 1996; 2 (3) 287-292
    CrossrefPubMedSearch in Google Scholar
  • 29 Creemers E, Cleutjens J, Smits J , et al. Disruption of the plasminogen gene in mice abolishes wound healing after myocardial infarction. Am J Pathol 2000; 156 (6) 1865-1873
    CrossrefPubMedSearch in Google Scholar
  • 30 Madureira PA, Hill R, Miller VA, Giacomantonio C, Lee PW, Waisman DM. Annexin A2 is a novel cellular redox regulatory protein involved in tumorigenesis. Oncotarget 2011; 2 (12) 1075-1093
    PubMedSearch in Google Scholar
  • 31 Madureira PA, O'Connell PA, Surette AP, Miller VA, Waisman DM. The biochemistry and regulation of S100A10: a multifunctional plasminogen receptor involved in oncogenesis. J Biomed Biotechnol 2012; 2012: 353687
    PubMedSearch in Google Scholar
  • 32 Ranson M, Andronicos NM, O'Mullane MJ, Baker MS. Increased plasminogen binding is associated with metastatic breast cancer cells: differential expression of plasminogen binding proteins. Br J Cancer 1998; 77 (10) 1586-1597
    CrossrefPubMedSearch in Google Scholar
  • 33 Palumbo JS, Talmage KE, Liu H, La Jeunesse CM, Witte DP, Degen JL. Plasminogen supports tumor growth through a fibrinogen-dependent mechanism linked to vascular patency. Blood 2003; 102 (8) 2819-2827
    CrossrefPubMedSearch in Google Scholar
  • 34 Suelves M, López-Alemany R, Lluís F , et al. Plasmin activity is required for myogenesis in vitro and skeletal muscle regeneration in vivo. Blood 2002; 99 (8) 2835-2844
    CrossrefPubMedSearch in Google Scholar
  • 35 López-Alemany R, Suelves M, Muñoz-Cánoves P. Plasmin generation dependent on alpha-enolase-type plasminogen receptor is required for myogenesis. Thromb Haemost 2003; 90 (4) 724-733
    PubMedSearch in Google Scholar
  • 36 Lopez-Alemany R, Suelves M, Diaz-Ramos A, Vidal B, Munoz-Canoves P. Alpha-enolase plasminogen receptor in myogenesis. Front Biosci 2005; 10: 30-36
    CrossrefPubMedSearch in Google Scholar
  • 37 Jacovina AT, Zhong F, Khazanova E, Lev E, Deora AB, Hajjar KA. Neuritogenesis and the nerve growth factor-induced differentiation of PC-12 cells requires annexin II-mediated plasmin generation. J Biol Chem 2001; 276 (52) 49350-49358
    CrossrefPubMedSearch in Google Scholar
  • 38 Gutiérrez-Fernández A, Gingles NA, Bai H, Castellino FJ, Parmer RJ, Miles LA. Plasminogen enhances neuritogenesis on laminin-1. J Neurosci 2009; 29 (40) 12393-12400
    CrossrefPubMedSearch in Google Scholar
  • 39 Jiang Q, Taupenot L, Mahata SK , et al. Proteolytic cleavage of chromogranin A (CgA) by plasmin. Selective liberation of a specific bioactive CgA fragment that regulates catecholamine release. J Biol Chem 2001; 276 (27) 25022-25029
    CrossrefPubMedSearch in Google Scholar
  • 40 Bai H, Nangia S, Parmer RJ. The plasminogen activation system and the regulation of catecholaminergic function. J Biomed Biotechnol 2012; 2012: 721657
    PubMedSearch in Google Scholar
  • 41 Syrovets T, Lunov O, Simmet T. Plasmin as a proinflammatory cell activator. J Leukoc Biol 2012; 92 (3) 509-519
    CrossrefPubMedSearch in Google Scholar
  • 42 Li X, Syrovets T, Simmet T. The serine protease plasmin triggers expression of the CC-chemokine ligand 20 in dendritic cells via Akt/NF-κB-dependent pathways. J Biomed Biotechnol 2012; 2012: 186710
    PubMedSearch in Google Scholar
  • 43 Ling Q, Jacovina AT, Deora A , et al. Annexin II regulates fibrin homeostasis and neoangiogenesis in vivo. J Clin Invest 2004; 113 (1) 38-48
    CrossrefPubMedSearch in Google Scholar
  • 44 Dassah M, Deora AB, He K, Hajjar KA. The endothelial cell annexin A2 system and vascular fibrinolysis. Gen Physiol Biophys 2009; 28(Spec No Focus): F20-F28
    PubMedSearch in Google Scholar
  • 45 Surette AP, Madureira PA, Phipps KD, Miller VA, Svenningsson P, Waisman DM. Regulation of fibrinolysis by S100A10 in vivo. Blood 2011; 118 (11) 3172-3181
    CrossrefPubMedSearch in Google Scholar
  • 46 Madureira PA, Surette AP, Phipps KD, Taboski MA, Miller VA, Waisman DM. The role of the annexin A2 heterotetramer in vascular fibrinolysis. Blood 2011; 118 (18) 4789-4797
    CrossrefPubMedSearch in Google Scholar
  • 47 Pluskota E, Soloviev DA, Bdeir K, Cines DB, Plow EF. Integrin alphaMbeta2 orchestrates and accelerates plasminogen activation and fibrinolysis by neutrophils. J Biol Chem 2004; 279 (17) 18063-18072
    CrossrefPubMedSearch in Google Scholar
  • 48 Law RH, Caradoc-Davies T, Cowieson N , et al. The X-ray crystal structure of full-length human plasminogen. Cell Rep 2012; 1 (3) 185-190
    CrossrefPubMedSearch in Google Scholar
  • 49 Xue Y, Bodin C, Olsson K. Crystal structure of the native plasminogen reveals an activation-resistant compact conformation. J Thromb Haemost 2012; 10 (7) 1385-1396
    CrossrefPubMedSearch in Google Scholar
  • 50 Miles LA, Dahlberg CM, Plow EF. The cell-binding domains of plasminogen and their function in plasma. J Biol Chem 1988; 263 (24) 11928-11934
    PubMedSearch in Google Scholar
  • 51 Castellino FJ, Ploplis VA. Structure and function of the plasminogen/plasmin system. Thromb Haemost 2005; 93 (4) 647-654
    PubMedSearch in Google Scholar
  • 52 Violand BN, Sodetz JM, Castellino FJ. The effect of epsilon-amino caproic acid on the gross conformation of plasminogen and plasmin. Arch Biochem Biophys 1975; 170 (1) 300-305
    CrossrefPubMedSearch in Google Scholar
  • 53 Wiman B. Primary structure of peptides released during activation of human plasminogen by urokinase. Eur J Biochem 1973; 39 (1) 1-9
    CrossrefPubMedSearch in Google Scholar
  • 54 Wiman B, Wallén P. Activation of human plasminogen by an insoluble derivative of urokinase. Structural changes of plasminogen in the course of activation to plasmin and demonstration of a possible intermediate compound. Eur J Biochem 1973; 36 (1) 25-31
    CrossrefPubMedSearch in Google Scholar
  • 55 Violand BN, Castellino FJ. Mechanism of the urokinase-catalyzed activation of human plasminogen. J Biol Chem 1976; 251 (13) 3906-3912
    PubMedSearch in Google Scholar
  • 56 Han J, Baik N, Kim KH , et al. Monoclonal antibodies detect receptor-induced binding sites in Glu-plasminogen. Blood 2011; 118 (6) 1653-1662
    CrossrefPubMedSearch in Google Scholar
  • 57 Félez J, Jardí M, Fàbregas P, Parmer RJ, Miles LA. Monoclonal antibodies against receptor-induced binding sites detect cell-bound plasminogen in blood. Blood 2012; 120 (3) 678-681
    CrossrefPubMedSearch in Google Scholar
  • 58 Jardí M, Fàbregas P, Sagarra-Tió M, Pérez-Lucena MJ, Félez J. Characterization of plasminogen binding to NB4 promyelocytic cells using monoclonal antibodies against receptor-induced binding sites in cell-bound plasminogen. J Biomed Biotechnol 2012; 2012: 984589
    PubMedSearch in Google Scholar
  • 59 Dejouvencel T, Doeuvre L, Lacroix R , et al. Fibrinolytic cross-talk: a new mechanism for plasmin formation. Blood 2010; 115 (10) 2048-2056
    CrossrefPubMedSearch in Google Scholar
  • 60 Gong Y, Kim S-O, Felez J, Grella DK, Castellino FJ, Miles LA. Conversion of Glu-plasminogen to Lys-plasminogen is necessary for optimal stimulation of plasminogen activation on the endothelial cell surface. J Biol Chem 2001; 276 (22) 19078-19083
    CrossrefPubMedSearch in Google Scholar
  • 61 Miles LA, Castellino FJ, Gong Y. Critical role for conversion of glu-plasminogen to Lys-plasminogen for optimal stimulation of plasminogen activation on cell surfaces. Trends Cardiovasc Med 2003; 13 (1) 21-30
    CrossrefPubMedSearch in Google Scholar
  • 62 Zhang L, Gong Y, Grella DK, Castellino FJ, Miles LA. Endogenous plasmin converts Glu-plasminogen to Lys-plasminogen on the monocytoid cell surface. J Thromb Haemost 2003; 1 (6) 1264-1270
    CrossrefPubMedSearch in Google Scholar
  • 63 Thorsen S. The mechanism of plasminogen activation and the variability of the fibrin effector during tissue-type plasminogen activator-mediated fibrinolysis. Ann N Y Acad Sci 1992; 667: 52-63
    CrossrefPubMedSearch in Google Scholar
  • 64 Marshall JM, Brown AJ, Ponting CP. Conformational studies of human plasminogen and plasminogen fragments: evidence for a novel third conformation of plasminogen. Biochemistry 1994; 33 (12) 3599-3606
    CrossrefPubMedSearch in Google Scholar
  • 65 Hasumi K, Yamamichi S, Harada T. Small-molecule modulators of zymogen activation in the fibrinolytic and coagulation systems. FEBS J 2010; 277 (18) 3675-3687
    CrossrefPubMedSearch in Google Scholar
  • 66 Tsirka SE, Bugge TH, Degen JL, Strickland S. Neuronal death in the central nervous system demonstrates a non-fibrin substrate for plasmin. Proc Natl Acad Sci U S A 1997; 94 (18) 9779-9781
    CrossrefPubMedSearch in Google Scholar
  • 67 Chen ZL, Strickland S. Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin. Cell 1997; 91 (7) 917-925
    CrossrefPubMedSearch in Google Scholar
  • 68 Houard X, Monnot C, Dive V, Corvol P, Pagano M. Vascular smooth muscle cells efficiently activate a new proteinase cascade involving plasminogen and fibronectin. J Cell Biochem 2003; 88 (6) 1188-1201
    CrossrefPubMedSearch in Google Scholar
  • 69 Meilhac O, Ho-Tin-Noé B, Houard X, Philippe M, Michel JB, Anglés-Cano E. Pericellular plasmin induces smooth muscle cell anoikis. FASEB J 2003; 17 (10) 1301-1303
    CrossrefPubMedSearch in Google Scholar
  • 70 Zhang X, Chaudhry A, Chintala SK. Inhibition of plasminogen activation protects against ganglion cell loss in a mouse model of retinal damage. Mol Vis 2003; 9: 238-248
    PubMedSearch in Google Scholar
  • 71 Rossignol P, Ho-Tin-Noé B, Vranckx R , et al. Protease nexin-1 inhibits plasminogen activation-induced apoptosis of adherent cells. J Biol Chem 2004; 279 (11) 10346-10356
    CrossrefPubMedSearch in Google Scholar
  • 72 O'Mullane MJ, Baker MS. Loss of cell viability dramatically elevates cell surface plasminogen binding and activation. Exp Cell Res 1998; 242 (1) 153-164
    CrossrefPubMedSearch in Google Scholar
  • 73 O'Mullane MJ, Baker MS. Elevated plasminogen receptor expression occurs as a degradative phase event in cellular apoptosis. Immunol Cell Biol 1999; 77 (3) 249-255
    CrossrefPubMedSearch in Google Scholar
  • 74 Mitchell JW, Baik N, Castellino FJ, Miles LA. Plasminogen inhibits TNFalpha-induced apoptosis in monocytes. Blood 2006; 107 (11) 4383-4390
    CrossrefPubMedSearch in Google Scholar
  • 75 Pluskota E, Soloviev DA, Szpak D, Weber C, Plow EF. Neutrophil apoptosis: selective regulation by different ligands of integrin alphaMbeta2. J Immunol 2008; 181 (5) 3609-3619
    PubMedSearch in Google Scholar
  • 76 Casar B, He Y, Iconomou M, Hooper JD, Quigley JP, Deryugina EI. Blocking of CDCP1 cleavage in vivo prevents Akt-dependent survival and inhibits metastatic colonization through PARP1-mediated apoptosis of cancer cells. Oncogene 2012; 31 (35) 3924-3938
    CrossrefPubMedSearch in Google Scholar
  • 77 Deryugina EI, Quigley JP. Cell surface remodeling by plasmin: a new function for an old enzyme. J Biomed Biotechnol 2012; 2012: 564259
    PubMedSearch in Google Scholar
  • 78 Ranson M, Andronicos NM. Plasminogen binding and cancer: promises and pitfalls. Front Biosci 2003; 8: s294-s304
    CrossrefPubMedSearch in Google Scholar
  • 79 Andronicos NM, Chen EI, Baik N , et al. Proteomics-based discovery of a novel, structurally unique, and developmentally regulated plasminogen receptor, Plg-RKT, a major regulator of cell surface plasminogen activation. Blood 2010; 115 (7) 1319-1330
    CrossrefPubMedSearch in Google Scholar
  • 80 Wang GG, Calvo KR, Pasillas MP, Sykes DB, Häcker H, Kamps MP. Quantitative production of macrophages or neutrophils ex vivo using conditional Hoxb8. Nat Methods 2006; 3 (4) 287-293
    CrossrefPubMedSearch in Google Scholar
  • 81 Félez J, Miles LA, Fábregas P, Jardí M, Plow EF, Lijnen RH. Characterization of cellular binding sites and interactive regions within reactants required for enhancement of plasminogen activation by tPA on the surface of leukocytic cells. Thromb Haemost 1996; 76 (4) 577-584
    PubMedSearch in Google Scholar
  • 82 Swaisgood CM, Schmitt D, Eaton D, Plow EF. In vivo regulation of plasminogen function by plasma carboxypeptidase B. J Clin Invest 2002; 110 (9) 1275-1282
    CrossrefPubMedSearch in Google Scholar
  • 83 Miles LA, Dahlberg CM, Plescia J, Felez J, Kato K, Plow EF. Role of cell-surface lysines in plasminogen binding to cells: identification of alpha-enolase as a candidate plasminogen receptor. Biochemistry 1991; 30 (6) 1682-1691
    CrossrefPubMedSearch in Google Scholar
  • 84 Redlitz A, Fowler BJ, Plow EF, Miles LA. The role of an enolase-related molecule in plasminogen binding to cells. Eur J Biochem 1995; 227 (1–2) 407-415
    CrossrefPubMedSearch in Google Scholar
  • 85 Hembrough TA, Kralovich KR, Li L, Gonias SL. Cytokeratin 8 released by breast carcinoma cells in vitro binds plasminogen and tissue-type plasminogen activator and promotes plasminogen activation. Biochem J 1996; 317 (Pt 3) 763-769
    PubMedSearch in Google Scholar
  • 86 Kassam G, Le BH, Choi KS , et al. The p11 subunit of the annexin II tetramer plays a key role in the stimulation of t-PA-dependent plasminogen activation. Biochemistry 1998; 37 (48) 16958-16966
    CrossrefPubMedSearch in Google Scholar
  • 87 Choi KS, Fogg DK, Yoon CS, Waisman DM. p11 regulates extracellular plasmin production and invasiveness of HT1080 fibrosarcoma cells. FASEB J 2003; 17 (2) 235-246
    CrossrefPubMedSearch in Google Scholar
  • 88 Hawley SB, Tamura T, Miles LA. Purification, cloning, and characterization of a profibrinolytic plasminogen-binding protein, TIP49a. J Biol Chem 2001; 276 (1) 179-186
    PubMedSearch in Google Scholar
  • 89 Herren T, Burke TA, Das R, Plow EF. Identification of histone H2B as a regulated plasminogen receptor. Biochemistry 2006; 45 (31) 9463-9474
    CrossrefPubMedSearch in Google Scholar
  • 90 Dudani AK, Ganz PR. Endothelial cell surface actin serves as a binding site for plasminogen, tissue plasminogen activator and lipoprotein(a). Br J Haematol 1996; 95 (1) 168-178
    CrossrefPubMedSearch in Google Scholar
  • 91 Miles LA, Andronicos NM, Baik N, Parmer RJ. Cell-surface actin binds plasminogen and modulates neurotransmitter release from catecholaminergic cells. J Neurosci 2006; 26 (50) 13017-13024
    CrossrefPubMedSearch in Google Scholar
  • 92 Hajjar KA, Jacovina AT, Chacko J. An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II. J Biol Chem 1994; 269 (33) 21191-21197
    PubMedSearch in Google Scholar
  • 93 Fan ZQ, Larson PJ, Bognacki J , et al. Tissue factor regulates plasminogen binding and activation. Blood 1998; 91 (6) 1987-1998
    PubMedSearch in Google Scholar
  • 94 Miles LA, Dahlberg CM, Levin EG, Plow EF. Gangliosides interact directly with plasminogen and urokinase and may mediate binding of these fibrinolytic components to cells. Biochemistry 1989; 28 (24) 9337-9343
    CrossrefPubMedSearch in Google Scholar
  • 95 Miles LA, Ginsberg MH, White JG, Plow EF. Plasminogen interacts with human platelets through two distinct mechanisms. J Clin Invest 1986; 77 (6) 2001-2009
    CrossrefPubMedSearch in Google Scholar
  • 96 Gonzalez-Gronow M, Gawdi G, Pizzo SV. Plasminogen activation stimulates an increase in intracellular calcium in human synovial fibroblasts. J Biol Chem 1993; 268 (28) 20791-20795
    PubMedSearch in Google Scholar
  • 97 Lishko VK, Novokhatny VV, Yakubenko VP, Skomorovska-Prokvolit HV, Ugarova TP. Characterization of plasminogen as an adhesive ligand for integrins alphaMbeta2 (Mac-1) and alpha5beta1 (VLA-5). Blood 2004; 104 (3) 719-726
    CrossrefPubMedSearch in Google Scholar
  • 98 Parkkinen J, Raulo E, Merenmies J , et al. Amphoterin, the 30-kDa protein in a family of HMG1-type polypeptides. Enhanced expression in transformed cells, leading edge localization, and interactions with plasminogen activation. J Biol Chem 1993; 268 (26) 19726-19738
    PubMedSearch in Google Scholar
  • 99 Kanalas JJ, Makker SP. Identification of the rat Heymann nephritis autoantigen (GP330) as a receptor site for plasminogen. J Biol Chem 1991; 266 (17) 10825-10829
    PubMedSearch in Google Scholar
  • 100 Kanalas JJ. Analysis of plasmin binding and urokinase activation of plasminogen bound to the Heymann nephritis autoantigen, gp330. Arch Biochem Biophys 1992; 299 (2) 255-260
    CrossrefPubMedSearch in Google Scholar
  • 101 Eng JK, McCormick AL, Yates JRI. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J Am Soc Mass Spectrom 1994; 5: 976-989
    CrossrefPubMedSearch in Google Scholar
  • 102 Miles LA, Lighvani S, Baik N , et al. The plasminogen receptor, Plg-R(KT), and macrophage function. J Biomed Biotechnol 2012; 2012: 250464
    PubMedSearch in Google Scholar
  • 103 Liu M, Zhang S. A kringle-containing protease with plasminogen-like activity in the basal chordate Branchiostoma belcheri . Biosci Rep 2009; 29 (6) 385-395
    CrossrefPubMedSearch in Google Scholar
  • 104 Bai H, Baik N, Kiosses WB, Krajewski S, Miles LA, Parmer RJ. The novel plasminogen receptor, plasminogen receptor(KT) (Plg-R(KT)), regulates catecholamine release. J Biol Chem 2011; 286 (38) 33125-33133
    CrossrefPubMedSearch in Google Scholar
  • 105 Miles LA, Andronicos NM, Chen EI , et al. Identification of the novel plasminogen receptor, Plg-RKT. In: Man TK, Flores RJ, , eds. Proteomics/Book 1: Human Diseases and Protein Functions. Rijeka, Croatia: Intech; 2012: 219-238
    CrossrefSearch in Google Scholar
  • 106 Lighvani S, Baik N, Diggs JE, Khaldoyanidi S, Parmer RJ, Miles LA. Regulation of macrophage migration by a novel plasminogen receptor Plg-R KT. Blood 2011; 118 (20) 5622-5630
    CrossrefPubMedSearch in Google Scholar
  • 107 Correc P, Fondanèche M-C, Bracke M, Burtin P. The presence of plasmin receptors on three mammary carcinoma MCF-7 sublines. Int J Cancer 1990; 46 (4) 745-750
    CrossrefPubMedSearch in Google Scholar
  • 108 Miles LA, Hawley SB, Baik N, Andronicos NM, Castellino FJ, Parmer RJ. Plasminogen receptors: the sine qua non of cell surface plasminogen activation. Front Biosci 2005; 10: 1754-1762
    PubMedSearch in Google Scholar
  • 109 Plow EF, Doeuvre L, Das R. So many plasminogen receptors: why?. J Biomed Biotechnol 2012; 2012: 141806
    PubMedSearch in Google Scholar
  • 110 Das R, Burke T, Plow EF. Histone H2B as a functionally important plasminogen receptor on macrophages. Blood 2007; 110 (10) 3763-3772
    CrossrefPubMedSearch in Google Scholar
  • 111 O'Connell PA, Surette AP, Liwski RS, Svenningsson P, Waisman DM. S100A10 regulates plasminogen-dependent macrophage invasion. Blood 2010; 116 (7) 1136-1146
    CrossrefPubMedSearch in Google Scholar
  • 112 Gong Y, Hart E, Shchurin A, Hoover-Plow J. Inflammatory macrophage migration requires MMP-9 activation by plasminogen in mice. J Clin Invest 2008; 118 (9) 3012-3024
    CrossrefPubMedSearch in Google Scholar
  • 113 Wygrecka M, Marsh LM, Morty RE , et al. Enolase-1 promotes plasminogen-mediated recruitment of monocytes to the acutely inflamed lung. Blood 2009; 113 (22) 5588-5598
    CrossrefPubMedSearch in Google Scholar
  • 114 Rattner JB, Martin L, Waisman DM, Johnstone SA, Fritzler MJ. Autoantibodies to the centrosome (centriole) react with determinants present in the glycolytic enzyme enolase. J Immunol 1991; 146 (7) 2341-2344
    PubMedSearch in Google Scholar
  • 115 Ross M, Gerke V, Steinem C. Membrane composition affects the reversibility of annexin A2t binding to solid supported membranes: a QCM study. Biochemistry 2003; 42 (10) 3131-3141
    CrossrefPubMedSearch in Google Scholar
  • 116 Das R, Plow EF. Phosphatidylserine as an anchor for plasminogen and its plasminogen receptor, histone H2B, to the macrophage surface. J Thromb Haemost 2011; 9 (2) 339-349
    CrossrefPubMedSearch in Google Scholar
  • 117 Marguet D, Luciani MF, Moynault A, Williamson P, Chimini G. Engulfment of apoptotic cells involves the redistribution of membrane phosphatidylserine on phagocyte and prey. Nat Cell Biol 1999; 1 (7) 454-456
    CrossrefPubMedSearch in Google Scholar
  • 118 Callahan MK, Halleck MS, Krahling S, Henderson AJ, Williamson P, Schlegel RA. Phosphatidylserine expression and phagocytosis of apoptotic thymocytes during differentiation of monocytic cells. J Leukoc Biol 2003; 74 (5) 846-856
    CrossrefPubMedSearch in Google Scholar
  • 119 Zwaal RF, Comfurius P, Bevers EM. Surface exposure of phosphatidylserine in pathological cells. Cell Mol Life Sci 2005; 62 (9) 971-988
    CrossrefPubMedSearch in Google Scholar
  • 120 Díaz-Ramos A, Roig-Borrellas A, García-Melero A, López-Alemany R. α-Enolase, a multifunctional protein: its role on pathophysiological situations. J Biomed Biotechnol 2012; 2012: 156795
    PubMedSearch in Google Scholar
  • 121 Simon DI, Rao NK, Xu H , et al. Mac-1 (CD11b/CD18) and the urokinase receptor (CD87) form a functional unit on monocytic cells. Blood 1996; 88 (8) 3185-3194
    PubMedSearch in Google Scholar
  • 122 Jiang YP, Pannell R, Liu JN, Gurewich V. Evidence for a novel binding protein to urokinase-type plasminogen activator in platelet membranes. Blood 1996; 87 (7) 2775-2781
    CrossrefPubMedSearch in Google Scholar
  • 123 Felez J, Chanquia CJ, Fabregas P, Plow EF, Miles LA. Competition between plasminogen and tissue plasminogen activator for cellular binding sites. Blood 1993; 82 (8) 2433-2441
    PubMedSearch in Google Scholar
  • 124 Kassam G, Le BH, Choi KS , et al. The p11 subunit of the annexin II tetramer plays a key role in the stimulation of t-PA-dependent plasminogen activation. Biochemistry 1998; 37 (48) 16958-16966
    CrossrefPubMedSearch in Google Scholar
  • 125 Fogg DK, Bridges DE, Cheung KK , et al. The p11 subunit of annexin II heterotetramer is regulated by basic carboxypeptidase. Biochemistry 2002; 41 (15) 4953-4961
    CrossrefPubMedSearch in Google Scholar
  • 126 MacLeod TJ, Kwon M, Filipenko NR, Waisman DM. Phospholipid-associated annexin A2-S100A10 heterotetramer and its subunits: characterization of the interaction with tissue plasminogen activator, plasminogen, and plasmin. J Biol Chem 2003; 278 (28) 25577-25584
    CrossrefPubMedSearch in Google Scholar